Crisis of the Clinical Trials Staff Attrition After the COVID-19 Pandemic

202312 citationsJournal Articlegreen Open Access

Authors

Grace Y. Sun · Novartis (Switzerland)

Don S. Dizon · Novartis (Switzerland)

Connie M. Szczepanek · Novartis (Switzerland)

Daniel P. Petrylak · Novartis (Switzerland)

Dana B. Sparks · Novartis (Switzerland)

Catherine M. Tangen · Novartis (Switzerland)

Primo Lara ·

Abstract

A survey of clinical research professionals @SWOG indicate that 80% of clinical trial offices are understaffed. Addressing this is critical so progress for people with cancer continues. Read more about lessons learned in the #COVID19 pandemic and how it informs a path forward.

Topics & Keywords

COVID-19 and healthcare impacts Healthcare cost, quality, practices

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JCO Oncology Practice

Volume 19, Issue 8, pp. 533-535

DOI: 10.1200/op.23.00152

Field-Weighted Citation Impact: 2.76